These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36807831)

  • 1. Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.
    Hsu CL; Wang Y; Duan Y; Chu H; Hartmann P; Llorente C; Zhou R; Schnabl B
    Dig Dis Sci; 2023 Jul; 68(7):3059-3069. PubMed ID: 36807831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Model of Alcoholic Steatohepatitis.
    Bertola A
    Methods Mol Biol; 2020; 2164():145-157. PubMed ID: 32607891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fecal mycobiome in non-alcoholic fatty liver disease.
    Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
    J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice.
    Hendrikx T; Lang S; Rajcic D; Wang Y; McArdle S; Kim K; Mikulski Z; Schnabl B
    Gut; 2023 Oct; 72(10):1959-1970. PubMed ID: 36690432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice.
    Inamine T; Yang AM; Wang L; Lee KC; Llorente C; Schnabl B
    Alcohol Clin Exp Res; 2016 Dec; 40(12):2604-2613. PubMed ID: 27739086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
    Chen P; Torralba M; Tan J; Embree M; Zengler K; Stärkel P; van Pijkeren JP; DePew J; Loomba R; Ho SB; Bajaj JS; Mutlu EA; Keshavarzian A; Tsukamoto H; Nelson KE; Fouts DE; Schnabl B
    Gastroenterology; 2015 Jan; 148(1):203-214.e16. PubMed ID: 25239591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis.
    Luo Z; Ji Y; Zhang D; Gao H; Jin Z; Yang M; Ying W
    Acta Physiol (Oxf); 2022 Jul; 235(3):e13827. PubMed ID: 35500155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse model of chronic and binge ethanol feeding (the NIAAA model).
    Bertola A; Mathews S; Ki SH; Wang H; Gao B
    Nat Protoc; 2013 Mar; 8(3):627-37. PubMed ID: 23449255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Ambade A; Kodys K; Catalano D; Ward DV; Szabo G
    PLoS One; 2017; 12(3):e0174544. PubMed ID: 28350851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in
    Hoebinger C; Rajcic D; Silva B; Hendrikx T
    Front Endocrinol (Lausanne); 2023; 14():1148827. PubMed ID: 37560305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
    Cheng C; Tan J; Qian W; Zhang L; Hou X
    Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.
    Hendrikx T; Duan Y; Wang Y; Oh JH; Alexander LM; Huang W; Stärkel P; Ho SB; Gao B; Fiehn O; Emond P; Sokol H; van Pijkeren JP; Schnabl B
    Gut; 2019 Aug; 68(8):1504-1515. PubMed ID: 30448775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of CCl
    Brol MJ; Rösch F; Schierwagen R; Magdaleno F; Uschner FE; Manekeller S; Queck A; Schwarzkopf K; Odenthal M; Drebber U; Thiele M; Lingohr P; Plamper A; Kristiansen G; Lotersztajn S; Krag A; Klein S; Rheinwalt KP; Trebicka J
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G182-G194. PubMed ID: 31188634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.